Who Needs Gastroprotection in 2020?

Current Treatment Options in Gastroenterology
Takeshi Kanno, Paul Moayyedi

Abstract

Peptic ulcer disease (PUD) is a recognized complication of non-steroidal anti-inflammatory drugs (NSAIDs). Stress ulcers are a concern for intensive care unit (ICU) patients; PUD is also an issue for patients taking anticoagulation. Helicobacter pylori test and treat is an option for patients starting NSAID therapy, and proton pump inhibitors (PPIs) may reduce PUD in NSAID patients and other high-risk groups. There are a large number of trials that demonstrate that Helicobacter pylori eradication reduces PUD in NSAID patients. PPI is also effective at reducing PUD in this group and is also effective in ICU patients and those on anticoagulants. The effect is too modest for PPI to be recommended in everyone, and more research is needed as to which groups would benefit the most. Increasing age, past history of PUD, and comorbidity are the most important risk factors. H. pylori test and treat should be offered to older patients starting NSAIDS, while PPIs should be prescribed to patients that are at high risk of developing PUD and at risk of dying from PUD complications.

References

Feb 17, 1996·BMJ : British Medical Journal·K R NealR F Logan
Mar 1, 1996·Gut·T A RockallT C Northfield
Jul 25, 2000·The Cochrane Database of Systematic Reviews·A RostomJ McGowan
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·L MaJ L Wallace
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Dec 12, 2001·Critical Care : the Official Journal of the Critical Care Forum·D J CookUNKNOWN Canadian Critical Care Trials Group
Aug 28, 2002·The Annals of Pharmacotherapy·Michiel E H HemelsThomas R Einarson
Oct 12, 2002·BMJ : British Medical Journal·David A FitzmauriceGregory Y H Lip
Jan 10, 2003·The Cochrane Database of Systematic Reviews·A RostomJ McGowan
Jul 1, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Omar M E Abdel Salam
Oct 28, 2004·JAMA : the Journal of the American Medical Association·Robert J F LaheijJan B M J Jansen
Feb 3, 2005·BMJ : British Medical Journal·Grigoris I LeontiadisColin W Howden
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Jun 14, 2005·Alimentary Pharmacology & Therapeutics·M VergaraX Calvet
Jan 31, 2006·The American Journal of Medicine·Victor L Serebruany
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Yu-Xiao YangDavid C Metz
Apr 20, 2007·The Cochrane Database of Systematic Reviews·Mostafizur KhanPaul Moayyedi
Jun 9, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alaa RostomGeorge W Wells
Jun 14, 2008·Gastroenterology·Loren LaineAndrzej Tarnawski
Dec 5, 2008·Alimentary Pharmacology & Therapeutics·A RostomUNKNOWN Canadian Association of Gastroenterology Consensus Group
Feb 18, 2009·Alimentary Pharmacology & Therapeutics·J J Y SungH B El-Serag
Mar 5, 2009·JAMA : the Journal of the American Medical Association·P Michael HoJohn S Rumsfeld
Oct 1, 2009·Journal of Gastroenterology and Hepatology·K Ming FockUNKNOWN Second Asia-Pacific Conference

❮ Previous
Next ❯

Citations

May 28, 2021·Frontiers in Pharmacology·Rafael Fernades CostaJames Oluwagbamigbe Fajemiroye
Aug 28, 2021·Journal of Clinical Medicine·Irena Mladenova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved